Dharesh Raj Amarnath

1 Introduction Liver transplantation is the definitive treatment for patients with end-stage liver disease and some cancers [1]. However, liver shortages remain a major challenge, with approximately 12% of patients in the US waiting for more than 5 years for a transplant [2], many of whom either die or are removed from the waitlist. Strategies that expand the deceased-donor pool or improve organ utilization from existing donors are required to address this issue.